Cargando…
Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro
Breast cancer is the most common malignancy among females throughout the world. Current treatments have unsatisfactory outcomes due to the dispersed nature of certain types of the disease. The development of a more effective therapy for breast cancer has long been one of the most elusive goals of ca...
Autores principales: | LIU, XIAOYI, HU, JIANXIA, SUN, SUYUAN, LI, FUNIAN, CAO, WEIHONG, WANG, YU, MA, ZHONGLIANG, YU, ZHIGANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353741/ https://www.ncbi.nlm.nih.gov/pubmed/25780408 http://dx.doi.org/10.3892/etm.2015.2286 |
Ejemplares similares
-
[Corrigendum] Mesenchymal stem cells expressing interleukin‑18 suppress breast cancer cells in vitro
por: Liu, Xiaoyi, et al.
Publicado: (2023) -
Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model
por: Liu, Xiaoyi, et al.
Publicado: (2018) -
[Corrigendum] Mesenchymal stem cells expressing interleukin‑18 inhibit breast cancer in a mouse model
por: Liu, Xiaoyi, et al.
Publicado: (2023) -
Interleukin-17 enhances immunosuppression by mesenchymal stem cells
por: Han, X, et al.
Publicado: (2014) -
Human Mesenchymal Stem Cells Overexpressing Interleukin 2 Can Suppress Proliferation of Neuroblastoma Cells in Co-Culture and Activate Mononuclear Cells In Vitro
por: Chulpanova, Daria S., et al.
Publicado: (2020)